Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma
Crossref DOI link: https://doi.org/10.1186/s12885-020-07536-3
Published Online: 2020-10-21
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Ying
Zhao, Bo
Wang, Xiaohu http://orcid.org/0000-0002-0701-7353
Text and Data Mining valid from 2020-10-21
Version of Record valid from 2020-10-21
Article History
Received: 4 June 2020
Accepted: 16 October 2020
First Online: 21 October 2020
Ethics approval and consent to participate
: Not applicable.
: The authors declare that they have no competing interests.